India Pharmaceutical Glass Packaging Market – Industry Trends and Forecast to 2028

Market Analysis and Insights: India Pharmaceutical Glass Packaging Market

India pharmaceutical glass packaging market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing at a CAGR of 6.8% in the forecast period of 2021 to 2028 and is expected to reach USD 432,639.00 thousand by 2028.

The growing health awareness and adoption of new techniques for the storage of liquid drugs drive the market. The increasing cost of overall drug packaging acts as a restraint to the market. The growing demand for ready-to-use glass vials plays as an opportunity for pharmaceutical glass packaging manufacturing. The increasing stringent government regulations relating to pharmaceutical glass packaging can be a challenge for manufacturers,

Pharmaceutical glass packaging includes bottles, vials, cartridges that are small in size and are used in the holding of medicines that are helpful in various end-user areas. Pharmaceutical glass packaging has been growing due to the increasing usage of generic injectable drugs in the healthcare industry. The pharmaceutical glass packaging is available in various drug types, such as injectable and non-injectable. The major property of the pharmaceutical glass packaging has high chemical durable properties, which maximizes the reliability of the products.

Several manufacturers are engaged in producing high-quality packing products from glass, which can help increase the shelf life of pharmaceutical products. The multilayer design packaging products in the pharmaceutical industry offers additional integrity assurance, even under force impact. For the packaging of toxic or high potency drug solutions, the demand for the combined crack resistance and integrity performance packaging products is increasing in the pharmaceutical industry.

This pharmaceutical glass packaging market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.

India Pharmaceutical Glass Packaging Market Scope and Market Size

India Pharmaceutical glass packaging market is segmented into material, product, drug type, application, and end-user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of material, the market is segmented into Type I, Type II, and Type III. In India, type I is expected to dominate the market because of the easy availability of raw materials, maximizing the demand for pharmaceutical glass packaging.
• On the basis of product, the market is segmented into bottles, ampoules, cartridges and syringes, vials, and others. In India, bottles are expected to dominate the market because of growing applications in end products.
• On the basis of drug type, the market is segmented into generic, branded, and biologic. In India, generic is expected to dominate the market because it requires less marketing efforts.
• On the basis of application, the market is segmented into nasal, oral, injectable, and others. In India, oral is expected to dominate the market because of easy availability.
• On the basis of end-user, the market is segmented into pharmaceutical companies, biopharmaceutical companies, contract development and manufacturing companies, compound pharmacy, and others. In India, pharmaceutical companies are expected to dominate the market because of growing usage among end-users.  

Pharmaceutical Glass Packaging Market Country Level Analysis

India Pharmaceutical glass packaging market is segmented into material, product, drug type, application, and end-user.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.

Growing demand for ready-to-use glass vials for flexible aseptic filling

India pharmaceutical glass packaging market also provides you with detailed market analysis for every country growth in an installed base of different kinds of products for the pharmaceutical glass packaging market, impact of technology using lifeline curves and changes in infant formula regulatory scenarios, and their impact on the pharmaceutical glass packaging market. The data is available for the historical period 2010 to 2019.

Competitive Landscape and Pharmaceutical Glass Packaging Market Share Analysis

India pharmaceutical glass packaging market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, brand analysis, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the focus of the India pharmaceutical glass packaging market.

• The major players covered in the report are NIPRO, Gerresheimer AG, SGD Pharma (a subsidiary of Saint-Gobain), SCHOTT AG, FRIGOGLASS, Hindustan National Glass & Industries Limited., and West Pharmaceutical Services, Inc., other players domestic and global. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

For instance,

• In January 2019, SCHOTT AG expanded the new production facilities in China and Germany and the capacity expansion in Switzerland and India. This update helps the company to increase production capacity, which generates revenue in the future.

SKU-65851